Received Sep 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | ey57a | — |
it was administered using an IM technique, but a SC needle length was used; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect needle gauge used in a 50-year-old male patient who received HAV (Havrix) (batch number ey57a, expiry date 03-OCT-2026) for prophylaxis. On 28-AUG-2025, the patient received Havrix. On 28-AUG-2025, an unknown time after receiving Havrix, the patient experienced incorrect needle gauge used (Verbatim: it was administered using an IM technique, but a SC needle length was used). The outcome of the incorrect needle gauge used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-AUG-2025 Reporter stated that they had a vaccination that was inappropriately administered. It was administered using an intramuscular IM technique, but a subcutaneous SC needle length was used. The Vaccine Administration Facility was the same as Primary Reporter. Healthcare professional reported that they used a 5/8 needle, instead of a 1 inch needle.